Quanterix Corporation Common Stock
Symbol: QTRX (NASDAQ)
Company Description:
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $5.54
- Yesterday High: $5.64
- Yesterday Low: $5.37
- Yesterday Volume: 440.62K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
- Name: Quanterix Corporation Common Stock
- Website: https://www.quanterix.com
- Listed Date: 2017-12-07
- Location: BILLERICA, MA
- Market Status: Active
- CIK Number: 0001503274
- SIC Code: 3826
- SIC description: LABORATORY ANALYTICAL INSTRUMENTS
- Market Cap: $257.42M
- Round Lot: 100
- Outstanding Shares: 46.47M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-09-24 | DEFA14A | View |
2025-09-24 | 8-K | View |
2025-09-23 | 8-K/A | View |
2025-09-17 | 4 | View |
2025-09-17 | 4 | View |
2025-09-17 | 4 | View |
2025-09-03 | 4 | View |
2025-08-25 | ARS | View |
2025-08-25 | DEF 14A | View |
2025-08-19 | 4 | View |
2025-08-19 | 4 | View |
2025-08-13 | SCHEDULE 13G/A | View |
2025-08-08 | PRE 14A | View |
2025-08-07 | 10-Q | View |
2025-08-07 | 8-K | View |
2025-08-04 | 8-K | View |
2025-08-04 | 4 | View |
2025-07-24 | 8-K | View |
2025-07-18 | 8-K | View |
2025-07-17 | SCHEDULE 13G/A | View |